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Abstract
The management of complicated urinary tract infection (UTI) remains a challenge since 
the coexisted conditions may significantly decrease the successful rate of treatment. In 
this chapter, the specific conditions including indwelling catheter, urolithiasis, neuro-
genic bladder, vesicoureteral reflux and pregnancy are listed. In terms of each condi-
tion, the potential influence on UTI and management strategy is discussed. Not only is 
the current evidence reviewed but also we present our experience on management of  
complicated UTI.
Keywords: urinary tract infection, catheter, urolithiasis, neurogenic bladder, 
vesicoureteral reflux, pregnancy
1. Introduction
Urinary tract infection (UTI), defined as an inflammatory response of the urothelium induced 
by a pathogenic organism, is one of the most common infectious diseases. It is estimated that 
one-third of the women may experience UTI by the age of 24, and half of the women suffer 
from at least one symptomatic UTI during their lifetime [1]. Basically, UTI can be classified as 
uncomplicated and complicated infection. The former is normally confined to bladder, which 
can be treated by short-course antibiotics. The latter refers to an infection associated with 
a condition which can increase the rate of therapy failures significantly. It is reported that 
25–30% of adult women with UTI have at least one risk factor causing complicated UTI [2]. 
The common conditions which may result in complicated UTI are presented in Table 1. Not 
only do these factors decrease treatments’ successful rate but also increase the recurrence risk 
of UTI. Therefore, when a complicated UTI is treated, management of the conditions needs to 
be taken into consideration.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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2. Catheter-associated UTI
Catheter-associated UTI is one of the most common complicated UTIs. It has been reported 
that catheter-associated UTI may lengthen the patients’ hospital stay and increase the mortality 
and the direct medical cost [3, 4]. Typically, the microorganisms can enter urinary tract through 
the extraluminal or intraluminal route. The former means microbial pathogens can invade the 
bladder through the gap between the catheter and urethra, whereas the latter indicates that 
causative agents migrate to bladder along the internal lumen of the catheter. According to the 
data from National Healthcare Safety Network (NHSN), the top three pathogens causing cathe-
ter-associated UTI are Escherichia coli (21.4%), Candida spp. (21.0%) and Enterococcus spp. (14.9%), 
followed by Pseudomonas aeruginosa (10.0%), Klebsiella pneumoniae (7.7%) and Enterobacter spp. 
(4.1%) [5]. With the duration of catheterization prolonging, the pathogens may induce the 
formation of biofilm on the surface of the catheter, which causes the occurrence of antibiotic 
resistance [6]. Traditionally, antimicrobial therapy was considered as a prevention strategy for 
catheter-associated UTI. However, a survey in two Dutch district hospitals showed that the use 
of antibiotics was associated with the development of bacteriuria in patients catheterized for 
3–14 days [7]. A recent cohort study further revealed that empirical antibiotic treatment had no 
effect on patients’ prognosis [8]. Both European Association of Urology (EAU) and Infectious 
Diseases Society of America (IDSA) guidelines recommend against the use of systemic antimi-
crobial prophylaxis for catheter-associated UTI [9, 10]. By contrast, the consistent recommenda-
tion identified across guidelines is removal of the catheter as soon as possible. However, some 
patients have to be catheterized for a long time due to various disorders. For those patients, 
some practical strategies are developed to prevent and manage the catheter-associated UTI.
2.1. Alternatives to indwelling urethral catheter
Instead of indwelling urethral catheterization, some alternative approaches have been devel-
oped to minimize the catheter-associated UTI. Those approaches include use of external 
Category Specific conditions
Foreign bodies Indwelling catheter
Urolithiasis
Structural or functional abnormality of urinary tract Neurogenic bladder
Vesicoureteral reflux
Obstructive uropathy
Others Pregnancy
Diabetes mellitus
Renal failure
Immunosuppression after kidney transplantation
Table 1. Specific conditions causing complicated UTI.
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catheter, intermittent catheterization and suprapubic catheterization. Condom catheter is the 
most common external equipment, which is suitable for patients with severe storage lower 
urinary tract dysfunction such as urinary incontinence. It has been reported that condom 
catheter has a significant advantage in comparison with indwelling catheter. A random-
ized controlled trail (RCT) demonstrated that condom catheter might reduce 80% risks of 
catheter-associated UTI or death compared to indwelling catheter. Additionally, patients 
with condom catheter presented a significant higher satisfaction rate than ones with the 
indwelling catheter [11].
For patients with severe voiding lower urinary tract dysfunction, intermittent or suprapubic 
catheterization is an option to replace indwelling catheter. An early study investigated the 
incidence of bacteriuria in patients with intermittent or indwelling catheterization. Based on 
the results of urine culture, 32% of patients treated with intermittent catheterization had bacte-
riuria, which is significantly lower than 61% in ones with an indwelling catheter [12]. Another 
study revealed that patients with intermittent catheterization had less chance to suffer from 
pyelonephritis than the counterparts with indwelling catheterization (5 vs. 25%, P < 0.01) [13]. 
In a multicentered RCT, 87 patients with a postvoid residual (PVR) bladder volume of more 
than 150 ml were allocated to receive intermittent or indwelling catheterization. After 3 days, 
a significant lower risk of developing bacteriuria was found in the intermittent catheterization 
group compared with the indwelling catheterization group (14 vs. 38%, P = 0.02), so was the 
risk of UTI (12 vs. 33%, P = 0.03). In terms of patients’ satisfaction, no marked difference was 
found between these two groups [14].
In general, intermittent catheterization can be practiced by a clean or sterile technique. 
Originally, sterile intermittent catheterization was applied as a standard method. In 1947, 
Guttman published the first report about sterile intermittent catheterization. In the report, he 
showed that this technique could decrease the risk of UTI and might be helpful for patients’ 
recovery of micturition. About 19 years later, Guttman further reported his experience in the 
use of sterile intermittent catheterization. During 11 years, he applied this technique to man-
age a total of 476 patients. Based on the data from 409 males, the technique was related to 
an extremely low incidence in UTI, vesicoureteral reflux, hydronephrosis and urolithiasis. 
Although sterile intermittent catheterization has some advantages, it is costly and time-con-
suming. In 1970, Hence Lapides and Betty S. Lowe introduced another technique, that is, 
clean and intermittent self-catheterization. Subsequently, they published a series of articles in 
which they showed that this technique could not increase the incidence of UTI. Later, a num-
ber of emerged evidence suggested that sterile intermittent catheterization could not provide 
an extra benefit compared to clean techniques. Two RCTs demonstrated that different tech-
nique was associated neither with overgrowth of microorganisms in urinary tract nor with the 
symptomatic UTI [15, 16].
Suprapubic catheterization provides a treatment option for patients who are not suitable for 
intermittent catheterization such as those with low compliance bladder. Evidence has illustrated 
that suprapubic catheter may bring more benefits for patients compared to transurethral cathe-
ter. A retrospective cohort study showed that patients with suprapubic catheter had less clinical 
visits due to pain than ones with indwelling urethral catheter [17]. The result from a meta-
analysis revealed that suprapubic catheterization was associated with a significant lower risk of 
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bacteriuria and less discomfort compared with transurethral catheter [18]. A prospective open-
labeled study presented that women with postoperative urinary retention favored suprapubic 
catheter due to a better catheter-specific quality of life [19]. According to the result from a 
network meta-analysis, indwelling urethral catheter did not increase the risk of UTI compared 
with either suprapubic tube or intermittent catheterization when duration of catheter was 
less than 5 days. In contrast, suprapubic tube or intermittent catheterization was associated 
with a lower rate of UTI when long-term catheterization is needed [20]. Based on our experi-
ence, suprapubic catheter has a significant advantage for male patients. We used suprapubic 
catheter to manage more than 20 male patients who suffered from recurrent acute bacterial 
prostatitis or epididymitis secondary to indwelling urethral catheter. We found that no one 
experienced these genitourinary infections again after the technique of catheterization was 
changed. Additionally, suprapubic catheter allows patients to observe their recovery of void-
ing function. We encourage patients to try to urinate with a closed suprapubic catheter if they 
have a low detrusor leak-point pressure (<40 cmH20) assessed by urodynamics, which means patients’ attempt of voiding cannot bring about upper urinary tract deterioration. After spon-
taneous voiding, patients need to open the suprapubic catheter and measure the PVR. Once 
the PVR is low enough, the removal of suprapubic catheter can be taken into consideration.
2.2. Catheter selection
To prevent the catheter-associated UTI, some special catheters have been designed and developed. 
They mainly include silver-coated, antibiotic-coated, hydrophilic and novel trefoil catheters.
As is known, silver is a kind of antiseptic. So it was hypothesized that catheter coated with 
silver could reduce the risk of UTI in patients treated by the indwelling catheter. Based on 
this hypothesis, a variety of silver-coated catheters have been developed. However, the effi-
cacy of these catheters on UTI prevention varies from one to another. Evidence showed that 
silver alloy-coated catheter might reduce the incidence of UTI, but the silver oxide-coated 
one would not. A prospective single-center study conducted in Hong Kong investigated the 
incidence of UTI in patients with a silver alloy and hydrogel-coated catheter, which was com-
pared with the counterparts with a standard catheter. The results showed that the incidence 
of UTI per 1000 catheter days was 6.4 and 9.4 in the silver-coated catheter group and standard 
catheter group, respectively. The silver-coated catheter group presented a 31% reduction in 
risk of UTI [21]. Lederer et al. reported the similar results in a retrospective cohort study in 
which 7 medical centers with 2778 active acute care beds in the United States were involved. 
They found that the silver alloy and hydrogel-coated catheter could cause a 47 and 58% rela-
tive reduction in UTI rate, respectively, compared to the conventional catheter when a differ-
ent definition was applied [22]. In contrast, two clinical trials revealed that the use of silver 
oxide-coated catheter could not reduce the incidence of UTI and bacteriuria in comparison 
with standard catheter [23, 24]. Besides the two silver-coated catheters mentioned earlier, 
another silver nanoparticle-fabricated catheter has been developed. According to an experi-
mental study, this silver nanoparticle catheter had significant antimicrobial and antibiofilm 
properties, as well as a remarkable ability to cause disorganization of bacterial cell membrane, 
which may prevent UTI effectively [25].
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It has been shown that antibiotic-coated catheter has a significant antimicrobial activity. 
Desai et al. found that nitrofurazone-impregnated catheter could decrease the adherence of 
pathogenic microorganisms to catheter markedly, but the effect could only persist for 5 days 
after the catheterization [26]. Regev-Shoshani et al. further reported that both nitrofurazone- 
and nitric oxide-coated catheters had a great effect on the prevention of microbial growth and 
biofilm formation, which was more effective than silver-coated catheter [27]. Despite lack of 
available clinical data so far, the antibiotic-coated catheter may bring potential benefits for 
patients with indwelling catheter.
Hydrophilic catheter may decrease the friction between catheter and urethra during catheter-
ization. Consequently, it reduces the potential mucosal trauma which can result in the bacte-
rial colonization. A multicentered RCT showed that the use of hydrophilic catheter might 
decrease approximately one-third the risk of developing symptomatic UTI compared with 
standard catheter [28]. Similarly, the evidence from a meta-analysis supported marked ben-
efits of hydrophilic catheter in terms of the incidence of UTI [29].
A novel trefoil catheter has been developed. Although it has not been reported for use in clini-
cal practice, the preclinical study has shown its advantages. Sun et al. performed an experi-
ment in which 66 rabbits were catheterized using either conventional or novel trefoil catheter 
randomly and reported that the novel catheter could decrease the incidence of bacteriuria. 
In addition, it was also found that the trefoil catheter caused a significant slighter mucosal 
inflammation than conventional catheter based on endoscopic assessment [30].
2.3. Catheter care
Catheter care is important for patients with an indwelling catheter since appropriate care 
can decrease the incidence of UTI. Both EAU and IDSA guidelines recommend maintain-
ing a closed drainage system all the time [9, 10]. Once any breaks are detected, both the 
catheter and collecting system must be replaced as soon as possible. Besides, it is crucial to 
keep the drainage tubing being below the level of the patient’s bladder and above the level 
of the collection bag, which can avoid the reflux of urine in drainage system. To minimize 
the risk of UTI, different types of collecting systems were developed. However, current 
evidence fails to show their different effects on prevention of UTI. Sullivan et al. conducted 
a RCT, in which 51 hospitalized dogs were catheterized with either an open or closed urine 
collection system. After analyzing the incidence of bacteriuria, they concluded that the type 
of urine collection system (open vs. closed) was not associated with the risk of developing 
bacteriuria [31].
In terms of the time point to change catheter, most guidelines recommend against changing 
catheter routinely. Instead, it is recommended to change the catheter before blockage occurs. 
Furthermore, some strategies including bladder irrigation with citric acid solution and oral 
acetohydroxamic acid have been proven to be effective for prevention of catheter block-
age [32, 33]. By contrast, bladder washing with saline is not recommended due to lack of 
effectiveness [34].
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3. Urolithiasis
Urolithiasis is one of the most common urological diseases with a rising incidence around 
the world. In general, UTI is usually considered as a complication of urolithiasis. Actually, it 
is also a potential pathogenic factor for a special urinary stone, struvite. Basically, the forma-
tion of struvite originates with the bacterial decomposition for urea. Some bacteria, including 
Proteus and Klebsiella, can decompose urea into ammonia and carbon dioxide, which can be 
further converted into ammonium and bicarbonate, respectively, and consequently, elevate 
the pH value of urine. With an alkaline urinary environment, the ammonium has a strong 
ability to combine with magnesium and phosphate. Once these chemical substances become 
supersaturated in urine, they will crystallize and deposit the struvite. The existence of urinary 
stone, especially struvite, may cause UTI difficult to treat because the stone may act as a nidus 
for microorganisms and result in obstruction in urinary tract.
According to our experience, when UTI and urolithiasis coexist, the individualized manage-
ment strategy should be taken into consideration. If the stone causes a urinary tract obstruc-
tion, the initial treatment should focus on the decompression of the collecting system, which 
can avoid the infection being exacerbated. Normally, the best way of decompression is to 
remove the stone as soon as possible, which can be achieved either by ureteroscopic litho-
tripsy or by percutaneous nephrolithotripsy. However, if the patient cannot tolerate these 
minimally invasive surgeries, indwelling ureteral stent and percutaneous nephrostomy tube 
could be the optional treatment. Only with an unobstructed collecting system can the subse-
quent antibiotic therapy for UTI be efficient. For patients with coexistence of UTI and nonob-
structive stone, empiric antibiotic therapy can be the initial treatment. Only when the UTI fails 
to manage, the invasive intervention is considered to remove the stone.
4. Neurogenic bladder
Neurogenic bladder refers to the bladder dysfunction secondary to a certain disease of the central 
nervous system or peripheral nerves. The specific conditions causing neurogenic bladder are var-
ious and the most common one is spinal cord injury, followed by multiple sclerosis, cerebral vas-
cular events and Parkinson’s disease [35]. Moreover, long-standing diabetes plays an important 
role in the development of neurogenic bladder. It is reported that patients with neurogenic blad-
der have a significant increased incidence of UTI. An observational study in which 46,000 patients 
with neurogenic bladder were investigated and followed up showed that 29.2–36.4% of patients 
were diagnosed with lower UTI annually [35]. Another study revealed that 81% of patients with 
spinal cord injury experienced at least one UTI during a period of 5 years [36]. The etiology of 
UTI caused by neurogenic bladder is diverse. It is reported that the bladder ischemia and defect 
of glycosaminoglycan layer induced by bladder overdistension reduce the barrier function of 
urothelium [37, 38]. Moreover, immunological impairment of bladder mucosa involving NK cell, 
B and T cell further decreases the bladder’s ability to defend the pathogens [39, 40].
For patients with neurogenic bladder, the clean intermittent self-catheterization is the most 
common technique to avoid bladder overdistension. It remains a big issue whether prophylactic 
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antibiotics can prevent bacteriuria and UTI in patients performing clean intermittent self-
catheterization due to neurogenic bladder. Two double-blind, placebo-controlled, crossover 
trials showed that nitrofurantoin prophylaxis could reduce the risk of bacteriuria and UTI 
significantly [41, 42]. On the contrary, a Cochrane systematic review demonstrated that the 
evidence failed to prove the certain benefits of antibiotic prophylaxis in patients with clean 
intermittent self-catheterization [43]. In a recently published case series study, Cox L et al. 
described a successful treatment in reduction of UTI in patients with clean intermittent self-
catheterization using intravesical instillations of gentamicin [44]. However, the treatment 
strategy needs to be further verified by well-designed RCTs.
5. Vesicoureteral reflux
Vesicoureteral reflux is the most common risk factor for UTI in children. It is reported that 
30–40% of children with their first UTI episode are affected by this disorder [45, 46]. In general, 
vesicoureteral reflux is graded from I to V (mild to severe) according to the height of reflux up 
the ureter and degree of dilatation of the ureter. A high grade of vesicoureteral reflux, defined 
as grade IV and V, may lead to the renal scars due to UTI, which may further cause renal fail-
ure. Conventionally, antibiotic prophylaxis has been considered as the standard management 
for patients with vesicoureteral reflux. However, a large cohort study revealed that continuous 
antibiotic prophylaxis could not decrease the risk of recurrent UTI but might increase the risk 
of bacteria resistant to the antibiotic in children with vesicoureteral reflux [47]. As an approach 
to eliminate reflux, some invasive interventions including anti-reflux surgery and injection of 
bulking agent are used to reduce the breakthrough UTI. Basically, the surgical options include 
open or laparoscopic ureteral reimplantation. Based on clinical assessment, the reported suc-
cessful rate for open and laparoscopic approach is 80–95% and 90–93%, respectively [48–50]. 
In contrast, the endoscopic injection presents a lower treatment successful rate in the range of 
50–93% [48]. From our experience, surgical intervention may be an effective therapy for the 
patients who still suffer from UTI even on continuous antibiotic prophylaxis.
6. Pregnancy
It is reported that pregnant women have an increasing risk of UTI, especially upper UTI, 
because the physiological changes induced by pregnancy make them more likely to suffer from 
pyelonephritis. On the one hand, elevated level of progesterone during pregnancy can induce 
the relaxation of ureteric smooth muscles, which may lead to the urine retention in the renal 
collecting system and ureter. On the other hand, the noticeable increase in renal blood volume 
and glomerular filtration rate may contribute to the renal pelvic and ureteral dilation. The 
dilated upper urinary tract provides pathogens with a permissive environment to grow and 
reproduce. As a result, bacteriuria will develop pyelonephritis in 25–40% of pregnant women. 
The independent risk factors include history of UTI, low socioeconomic status, indigence, 
intercurrent diabetes and sickle cell trait. Therefore, short-course antibiotic therapy should be 
applied to prevent developing ascending UTI, once the bacteriuria is identified in pregnant 
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women. It is investigated that the antibiotic therapy can reduce the incidence of pyelonephritis 
by 75% [51]. Generally, a three-day course of antibiotic therapy directed by urine culture is 
recommended for both symptomatic lower UTI and asymptomatic bacteriuria. When the result 
of culture is not available, an empiric therapy with a ß-lactam or nitrofurantoin can be used as 
the initial treatment. For patients with upper UTI, a 14- to 21-day course of intravenous anti-
biotic therapy should be adopted. The reported effective antibiotic includes a third-generation 
cephalosporin, gentamicin or aztreonam, which can be used as the initial treatment before the 
result of culture is available. In addition, it is crucial to identify whether an obstruction exists in 
every pregnant woman. Once the obstruction is diagnosed, it can be relieved by ureteral stent 
or percutaneous nephrostomy tube. For patients with ureteral stent or percutaneous nephros-
tomy tube, it is necessary to use the antibiotic continuously until after delivery.
7. Conclusion
The treatment of complicated UTI remains a challenge because the coexisted conditions are 
diverse. Appropriate management for these conditions is the prerequisite achieving a success-
ful treatment for complicated UTI.
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